Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Frost Ronald	2. Issuer Name and Ticker or Trading Symbol MERIT MEDICAL SYSTEMS INC [ MMSI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) CHIEF OPERATING OFFICER
(Last)          (First)          (Middle) 1600 WEST MERIT PARKWAY	3. Date of Earliest Transaction (MM/DD/YYYY) 6/15/2021
(Street) SOUTH JORDAN, UT 84095 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value	6/15/2021		M		20000	A	$17.27	22343	D
Common Stock, No Par Value	6/15/2021		S		11887	D	$61.82 (1)	10456	D
Common Stock, No Par Value								16283.643	I	By 401(k) plan (2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified stock options (right to buy)	$17.27	6/15/2021		M			20000	2/13/2016 (3)	2/13/2022	Common Stock	20000	$0	0	D
Non-qualified stock options (right to buy)	$16.05							1/28/2017 (4)	1/28/2023	Common stock	20000		20000	D
Non-qualified stock options (right to buy)	$28.20							4/14/2018 (5)	4/14/2024	Common Stock	50000		50000	D
Non-qualified stock options (right to buy)	$44.80							3/2/2019 (6)	3/2/2025	Common Stock	40000		40000	D
Non-qualified stock options (right to buy)	$55.73							3/1/2020 (7)	3/1/2026	Common Stock	30000		30000	D
Non-qualified stock options (right to buy)	$37.71							2/26/2021 (8)	2/26/2027	Common Stock	16722		16722	D
Non-qualified stock options (right to buy)	$56.25							3/19/2022 (9)	3/19/2028	Common Stock	9681		9681	D

Explanation of Responses:
(1)	The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.71 to $61.96, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
(2)	Represents plan holdings as of 06/16/2021.
(3)	Become exercisable in equal annual installments of 20% commencing 02/13/2016.
(4)	Become exercisable in equal annual installments of 20% commencing 01/28/2017.
(5)	Become exercisable in equal annual installments of 20% commencing 04/14/2018.
(6)	Become exercisable in equal annual installments of 20% commencing 03/02/2019.
(7)	Become exercisable in equal annual installments of 20% commencing 03/01/2020.
(8)	Become exercisable in equal annual installments of 25% commencing 02/26/2021.
(9)	Become exercisable in equal annual installments of 25% commencing 03/19/2022.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Frost Ronald 1600 WEST MERIT PARKWAY SOUTH JORDAN, UT 84095			CHIEF OPERATING OFFICER

Signatures
/s/ Brian G. Lloyd, Attorney-in-Fact		6/16/2021
**Signature of Reporting Person		Date